Epidemiology of breast cancer

Epidemiologic Reviews

Volumn 12, Issue 1, 1990, Pages 228-240

  Kelsey, Jennifer L ^a   Gammon, Marilie D ^a  

^a Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIETHYLSTILBESTROL; ESTROGEN RECEPTOR; MEDROXYPROGESTERONE ACETATE;

ADOLESCENT; ADULT; ALCOHOL CONSUMPTION; BREAST CANCER; CANCER RISK; ELECTROMAGNETIC FIELD; ESTROGEN THERAPY; FAMILIAL INCIDENCE; FEMALE; HEREDITY; HUMAN; LIFESTYLE; MAMMOGRAPHY; PRIORITY JOURNAL; RADIATION; REVIEW;

ADULT; BREAST NEOPLASMS; FEMALE; HUMAN; INCIDENCE; MIDDLE AGE; RISK FACTORS; WORLD HEALTH;

EID: 0025690751     PISSN: 0193936X     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.epirev.a036056     Document Type: Article

References (230)

1. Kelsey JL. A review of the epidemiology of human breast cancer. Epidemiol Rev 1979;1:74- 109.
2. Berkowitz GS, Kelsey JL. Epidemiology of breast cancer. In: Marchant DJ, ed. Diagnosis and management of breast cancer. New York, Elsevier (in press).
3. Kelsey JL, Berkowitz GS. Breast cancer epidemiology. Cancer Res 1988;48:5615-23.
4. Saftlas AF, Szklo M. Mammographie parenchymal patterns and breast cancer risk. Epidemiol Rev 1987;9:146-74.
5. Goodwin PJ, Boyd NF. Mammographic parenchymal pattern and breast cancer risk: a critical appraisal of the evidence. Am J Epidemiol 1988;127:1097-1108.
6. Stanford JL, Szklo M, Brinton LA. Estrogen receptors and breast cancer. Epidemiol Rev 1986;8:42-59.
7. Silverberg E, Boring CC, Squires TS. Cancer statistics, 1990. CA 1990;40:9-26.
8. Bethesda, MD: US Department of Health and Human Services, National Cancer Institute, 1988. (NIH publication no. 88-2789).
9. Miller AB, Bulbrook RD. UICC multidisciplinary project on breast cancer: the epidemiology, aetiology and prevention of breast cancer. Int J Cancer 1986;37:173-7.
10. Pathak DR, Speizer FE, Willett WC, et al. Parity and breast cancer risk: possible effect on age at diagnosis. Int J Cancer 1986;37:21-5.
11. Negri E, La Vecchia C, Bruzzi P, et al. Risk factors for breast cancer: pooled results from three Italian case-control studies. Am J Epidemiol 1988;128:1207-15.
12. Rosero-Bixby L, Oberle MW, Lee NC. Reproductive history and breast cancer in a population of high fertility, Costa Rica, 1984-85. Int J Cancer 1987;40:747-54.
13. Kvale G, Heuch I, Eide GE. A prospective study of reproductive factors and breast cancer. I. Parity. Am J Epidemiol 1987;126:831-41.
14. Brignone G, Cusimano R, Dardanoni G, et al. A case-control study on breast cancer risk factorsin a southern European population. Int J Epidemiol 1987;16:356-61.
15. Ewertz M, Duffy SW. Risk of breast cancer in relation to reproductive factors in Denmark. Br J Cancer 1988;58:99-104.
16. Yuan J-M, Yu MC, Ross RK, et al. Risk factors for breast cancer in Chinese women in Shanghai. Cancer Res 1988;48:1949-53.
17. Layde PM, Webster LA, Baughman AL, et al. The independent associations of parity, age at first full term pregnancy, and duration of breastfeeding with the risk of breast cancer. J Clin Epidemiol 1989;42:963-73.
18. Leon DA. A prospective study of the independent effects of parity and age at first birth on breast cancer incidence in England and Wales. Int J Cancer 1989;43:986-91.
19. Byers T, Graham S, Rzepka T, et al. Lactation and breast cancer: evidence for a negative association in premenopausal women. Am J Epidemiol 1985;121:664-74.
20. McTiernan A, Thomas DB. Evidence for a protective effect of lactation on risk of breast cancer in young women: results from a case-control study. Am J Epidemiol 1986;124:353-8.
21. Siskind V, Schofield F, Rice D, et al. Breast cancer and breastfeeding: results from an Australian case-control study. Am J Epidemiol 1989;130:229-36.
22. Lund E. Reproductive histories and premenopausal breast cancer: different estimates using population, neighborhood, or hospital controls. Cancer Res 1989;49:4015-19.
23. Hadjimichael OC, Boyle CA, Meigs JW. Abortion before first livebirth and risk of breast cancer. Br J Cancer 1986;53:281-4.
24. Rosenberg L, Palmer JR, Kaufman DW, et al. Breast cancer in relation to the occurrence and time of induced and spontaneous abortion. Am J Epidemiol 1988;127:981-9.
25. Howe HL, Senie RT, Bzduch H, et al. Early abortion and breast cancer risk among women under age 40. Int J Epidemiol 1989;18:300-4.
26. Brinton LA, Melton LJ, Malkasian GD, et al. Cancer risk after evaluation for infertility. Am J Epidemiol 1989;129:712-22.
27. Le MG, Bachelot A, Hill C. Characteristics of reproductive life and risk of breast cancer in a case-control study of young nulliparous women. J Clin Epidemiol 1989;42:1227-33.
28. Gammon MD, Thompson WD. Infertility and breast cancer: a population-based case-control study. Am J Epidemiol 1990;132:708-16.
29. Morabia A, Szklo M. Nulliparity, infertility and risk of breast cancer among premenopausal women. (Abstract). Am J Epidemiol 1989;130:811.
30. Cowan LD, Gordis L, Tonascia JA, et al. Breast cancer incidence in women with a history of progesterone deficiency. Am J Epidemiol 1981; 114:209-17.
31. Ron E, Lunenfeld B, Menczer J, et al. Cancer incidence in a cohort of infertile women. Am J Epidemiol 1987;125:780-90.
32. Henderson BE, Ross RK, Judd HL, et al. Do regular ovulatory cycles increase breast cancer risk? Cancer 1985;56:1206-8.
33. Coulam CB, Annegers JF, Kranz JS. Chronic anovulation syndrome and associated neoplasia. Obstet Gynecol 1983;61:403-7.
34. Kvåle G, Heuch I. A prospective study of reproductive factors and breast cancer. II. Age at first birth and last birth. Am J Epidemiol 1987;126:842-50.
35. Trichopoulos D, Hsieh C, MacMahon B, et al. Age at any birth and breast cancer risk. Int J Cancer 1983;31:701-4.
36. Le Marchand L, Kolonel LN, Myers BC, et al. Birth characteristics of premenopausal women with breast cancer. Br J Cancer 1988;57:437-9.
37. Thompson WD, Janerich DT. Maternal age at birth and risk of breast cancer in daughters. Epidemiology 1990;1:101-6.
38. Lubin F, Ruder AM, Wax Y, et al. Overweight and changes in weight throughout adult life in breast cancer etiology. Am J Epidemiol 1985; 122:579-88.
39. Le Marchand L, Kolonel LN, Earle ME, et al. Body size at different periods of life and breast cancer risk. Am J Epidemiol 1988;128:137-52.
40. Tornberg SA, Holm LE, Carstensen JM. Breast cancer risk in relation to serum cholesterol, serum beta-lipoprotein, height, weight, and blood pressure. Acta Oncol 1988;27:31-7.
41. London SJ, Colditz GA, Stampfer MJ, et al. Prospective study of relative weight, height, and risk of breast cancer. JAMA 1989;262:2853-8.
42. Swanson CA, Brinton LA, Taylor PR, et al. Body size and breast cancer risk assessed in women participating in the Breast Cancer Detection Demonstration Project. Am J Epidemiol 1989; 130:1133-41.
43. Tretli S. Height and weight in relation to breast cancer morbidity and mortality: a prospective study of 570,000 women in Norway. Int J Cancer 1989;44:23-30.
44. Ingram D, Nottage E, Ng S, et al. Obesity and breast disease: the role of the female sex hormones. Cancer 1989;64:1049-53.
45. Kolonel LN, Nomura AMY, Lee J, et al. Anthropometric indicators of breast cancer risk in postmenopausal women in Hawaii. Nutr Cancer 1986;8:247-56.
46. Folsom AR, Kaye SA, Prineas RJ, et al. Increased incidence of carcinoma of the breast associated with abdominal adiposity in postmenopausal women. Am J Epidemiol 1990;131:794-803.
47. Lapidus L, Helgesson ӧ, Merck C, et al. Adipose tissue distribution and female carcinomas: a 12-year follow-up of participants in the population study of women in Gothenburg, Sweden. Int J Obesity 1988;12:361-8.
48. Ballard-Barbash R, Schatzkin A, Carter C, et al. Body fat distribution and breast cancer in The Framingham Study. J Natl Cancer Inst 1990; 82:286-90.
49. Swanson CA, Jones DY, Schatzkin A, et al. Breast cancer risk assessed by anthropometry in the NHANES I Epidemiological Follow-up Study. Cancer Res 1988;48:5363-7.
50. Prentice RL, Thomas DB. On the epidemiology of oral contraceptives and disease. Adv Cancer Res 1987;49:285-401.
51. Rohan TE, McMichael AJ. Oral contraceptive agents and breast cancer: a population-based case-control study. Med J Aust 1988;149:520-6.
52. Miller DR, Rosenberg L, Kaufman DW, et al. Breast cancer before age 45 and oral contraceptive use: new findings. Am J Epidemiol 1989;129:269-80.
53. Stanford JL, Brinton LA, Hoover RN. Oral contraceptives and breast cancer: results from anexpanded case-control study. Br J Cancer 1989;60:375-81.
54. Ravnihar B, Zakelj MJ, Kosmelj K, et al. A case-control study of breast cancer in relation to oral contraceptive use in Slovenia. Neoplasma 1988;35:109-21.
55. Jick SS, Walker AM, Stergachis A, et al. Oral contraceptives and breast cancer. Br J Cancer 1989;59:618-21.
56. Hennekens CH, Speizer FE, Lipnick RJ, et al. A case-control study of oral contraceptive use and breast cancer. J Natl Cancer Inst 1984;72:39-42.
57. Olsson H, Moller TR, Ranstam J. Early oral contraceptive use and breast cancer among premenopausal women: final report from a study in southern Sweden. J Natl Cancer Inst 1989; 81:1000-4.
58. Meirik O, Lund E, Adami H-O, et al. Oral contraceptive use and breast cancer in young women: a joint national case-control study in Sweden and Norway. Lancet 1986;2:650-4.
59. UK National Case-Control Study Group. Oral contraceptive use and breast cancer risk in young women. Lancet 1989;1:973-82.
60. Pike MC, Henderson BE, Krailo MD, et al. Breast cancer in young women and use of oral contraceptives: possible modifying effect of formulation and age at use. Lancet 1983;2:926-30.
61. McPherson K, Vessey MP, Neil A, et al. Early oral contraceptive use and breast cancer: results of another case-control study. Br J Cancer 1987;56:653-60.
62. Stadel BV, Lai S, Schlesselman JJ, et al. Oral contraceptives and premenopausal breast cancer in nulliparous women. Contraception 1988;38: 287-99.
63. Lund E, Meirik O, Adami H-O, et al. Oral contraceptive use and premenopausal breast cancer in Sweden and Norway: possible effects of different pattern of use. Int J Epidemiol 1989;18:527-32.
64. Meirik O, Farley TMM, Lund E, et al. Breast cancer and oral contraceptives: patterns of risk among parous and nulliparous women—further analysis of the Swedish-Norwegian material. Contraception 1989;39:471-5.
65. Vessey MP, McPherson K, Villard-Mackintosh L, et al. Oral contraceptives and breast cancer:latest findings in a large cohort study. Br J Cancer 1989;59:613-17.
66. Rosenberg L, Miller DR, Kaufman DW, et al. Breast cancer and oral contraceptive use. Am J Epidemiol 1984;119:167-76.
67. Lipnick RJ, Buring JE, Hennekens CH, et al. Oral contraceptives and breast cancer: a prospective cohort study. JAMA 1986;255:58-61.
68. Paul C, Skegg DCG, Spears GFS, et al. Oral contraceptives and breast cancer: a national study. BMJ 1986;293:723-6.
69. Stadel BV, Schlesselman JJ. Oral contraceptiveuse and the risk of breast cancer in women with a “prior” history of benign breast disease. Am J Epidemiol 1986;123:373-82.
70. Lee NC, Rosero-Bixby L, Oberle MW, et al. A case-control study of breast cancer and hormonal contraception in Costa Rica. J Natl Cancer Inst 1987;79:1247-54.
71. Schlesselman JJ, Stadel BV, Murray P, et al. Breast cancer in relation to early use of oral contraceptives: no evidence of a latent effect. JAMA 1988;259:1828-33.
72. Dupont WD, Page DL, Rogers LW, et al. Influence of exogenous estrogens, proliferative breast disease, and other variables on breast cancer risk. Cancer 1989;63:948-57.
73. Murray PA, Stadel BV, Schlesselman JJ. Oral contraceptive use in women with a family history of breast cancer. Obstet Gynecol 1989;73:977-83.
74. Romieu I, Willett WC, Colditz GA, et al. Prospective study of oral contraceptive use and risk of breast cancer in women. J Natl Cancer Inst 1989;81:1313-21.
75. Kay CR, Hannaford PC. Breast cancer and the pill—a further report from the Royal College of General Practioners’ Oral Contraceptive Study. Br J Cancer 1988;58:675-80.
76. Peto J. Oral contraceptives and breast cancer. Is the CASH Study really negative? Lancet 1989;1:552.
77. Pike MC, Bernstein L. Oral contraceptives and breast cancer. Lancet 1989;1:615-16.
78. La Vecchia C, Decarli A, Fasoli M, et al. Oral contraceptives and cancers of the breast and of the female genital tract. Br J Cancer 1986; 54:311-17.
79. Stadel BV, Schlesselman JJ, Murray PA. Oral contraceptives and breast cancer. Lancet 1989; 1:1257-8.
80. Miller DR, Rosenberg L, Kaufman DW, et al. Breast cancer risk in relation to early oral contraceptive use. Obstet Gynecol 1986;68:836-8.
81. Greenspan AR, Hatcher RA, Moore M, et al. The association of depot-medroxyprogesterone acetate and breast cancer. Contraception 1980;21:563-9.
82. Liang AP, Levenson AG, Layde PM, et al. Risk of breast, uterine corpus, and ovarian cancer in women receiving medroxyprogesterone injections. JAMA 1983;249:2909-12.
83. Depot-medroxyprogesterone acetate (DMPA) and cancer: memorandum from a WHO meeting. Bull World Health Organ 1986;64:375-82.
84. Kaufman DW, Miller DR, Rosenberg L, et al. Noncontraceptive estrogen use and the risk of breast cancer. JAMA 1984;252:63-7.
85. Hulka BS, Chambless LE, Deubner DC, et al. Breast cancer and estrogen replacement therapy. Am J Obstet Gynecol 1982;143:638-44.
86. Buring JE, Hennekens CH, Lipnick RJ, et al. A prospective cohort study of postmenopausal hormone use and risk of breast cancer in US women. Am J Epidemiol 1987;125:939-47.
87. Brinton LA, Hoover R, Fraumeni JF Jr. Menopausal oestrogens and breast cancer risk: an expanded case-control study. Br J Cancer 1986; 54:825-32.
88. Wingo PA, Layde PM, Lee NC, et al. The risk of breast cancer in postmenopausal women who have used estrogen replacement therapy. JAMA 1987;257:209-15.
89. La Vecchia C, Decarli A, Parazzini F, et al. Noncontraceptive estrogens and the risk of breast cancer in women. Int J Cancer 1986;38:853-8.
90. Hiatt RA, Bawol R, Friedman GD, et al. Exogenous estrogen and breast cancer after bilateral oophorectomy. Cancer 1984;54:139-44.
91. Nomura AMY, Kolonel LN, Hirohata T, et al. The association of replacement estrogen with breast cancer. Int J Cancer 1986;37:49-53.
92. Hunt K, Vessey M, McPherson K, et al. Longterm surveillance of mortality and cancer incidence in women receiving hormone replacement therapy. Br J Obstet Gynaecol 1987;94:620-35.
93. Brinton LA, Hoover RN, Szklo M, et al. Menopausal estrogen use and risk of breast cancer.Cancer 1981;47:2517-22.
94. Ross RK, Paginini-Hill A, Gerkins VR, et al. A case-control study of menopausal estrogen therapy and breast cancer. JAMA 1980;243:1635-9.
95. Bergkvist L, Adami H-O, Persson I, et al. The risk of breast cancer after estrogen and estrogen-progestin replacement. N Engl J Med 1989; 321:293-7.
96. Beral V, Colwell L. Randomized trial of high doses of stilbestrol and ethisterone in pregnancy:long-term follow-up of mothers. BMJ 1980;281:1098-1101.
97. Vessey MP, Fairweather DVI, Norman-Smith B, et al. A randomized double-blind controlled trial of the value of stilbestrol therapy in pregnancy: long-term follow-up of mothers and their offspring. Br J Obstet Gynaecol 1983;30:1007-17.
98. Hadjimichael OC, Meigs JW, Faleier FW, et al. Cancer risk among women exposed to exogenous estrogens during pregnancy. J Natl Cancer Inst 1984;73:831-4.
99. Greenberg ER, Barnes AB, Resseguie L, et al. Breast cancer in mothers given diethylstilbestrol in pregnancy. N Engl J Med 1984;311:1393-8.
100. Willett WC, Stampfer MJ, Colditz GA, et al. Dietary fat and the risk of breast cancer. N Engl J Med 1987;316:22-8.
101. Graham S, Marshall J, Mettlin C, et al. Diet in the epidemiology of breast cancer. Am J Epidemiol 1982;116:68-75.
102. Hiatt RA, Friedman GD, Bawol RD, et al. Breast cancer and serum cholesterol. J Natl Cancer Inst 1982;68:885-9.
103. Phillips RL, Snowdon DA. Association of meat and coffee use with cancers of the large bowel, breast, and prostate among Seventh-Day Adventists: preliminary results. Cancer Res 1983;43 (suppl):2403s-8s.
104. Katsouyanni K, Trichopoulos D, Boyle P, et al. Diet and breast cancer: a case-control study in Greece. Int J Cancer 1986;38:815-20.
105. Wynder EL, Rose DP, Cohen LA. Diet and breast cancer in causation and therapy. Cancer 1986;58 (suppl):1804-13.
106. Hirohata T, Nomura AMY, Hankin JH, et al. An epidemiologic study on the association between diet and breast cancer. J Natl Cancer Inst 1987;78:595-600.
107. Jones DY, Schatzkin A, Green SB, et al. Dietary fat and breast cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. J Natl Cancer Inst 1987; 79:465-71.
108. Katsouyanni K, Willett W, Trichopoulos D, et al. Risk of breast cancer among Greek women in relation to nutrient intake. Cancer 1988;61:181- 5.
109. Mills PK, Annegers JF, Phillips RL. Animal product consumption and subsequent fatal breast cancer risk among Seventh-Day Adventists. Am J Epidemiol 1988;127:440-53.
110. Schatzkin A, Hoover RN, Taylor PR, et al. Site- specific analysis of total serum cholesterol and incident cancer in the National Health and Nutrition Examination Survey I Epidemiologic Follow-up Study. Cancer Res 1988;48:452-8.
111. La Vecchia C, Decarli A, Franceschi S, et al. Dietary factors and the risk of breast cancer. Nutr Cancer 1987;10:205-14.
112. Pryor M, Slattery ML, Robinson LM, et al. Adolescent diet and breast cancer in Utah. Cancer Res 1989;49:2161-7.
113. Rohan TE, McMichael AJ, Baghurst PA. A population-based case-control study of diet and breast cancer in Australia. Am J Epidemiol 1988;128:478-89.
114. Mills PK, Beeson WL, Phillips RL, et al. Dietary habits and breast cancer incidence among Seventh-Day Adventists. Cancer 1989;64:582- 90.
115. Aldercreutz H, Fotsis T, Bannwart C, et al. Urinary estrogen profile determination in young Finnish vegetarian and omnivorous women. J Steroid Biochem 1986;24:289-96.
116. Rose DP, Boyar AP, Cohen C, et al. Effect of low-fat diet on hormone levels in women with cystic breast disease. I. Serum steroid and gonadotropins. J Natl Cancer Inst 1987;78:623-6.
117. Goldin BR, Adlercreutz H, Gorbach SL, et al. Estrogen excretion patterns and plasma levels in vegetarian and omnivorous women. N Engl J Med 1982;307:1542-7.
118. Rose DP, Cohen LA, Berke B, et al. Effect of a low-fat diet on hormone levels in women with cystic breast disease. II. Serum radioimmuno- assayable prolactin and growth hormone and bioactive lactogenic hormones. J Natl Cancer Inst 1987;78:627-31.
119. Marubini E, Decarli A, Costa A, et al. The relationship of dietary intake and serum levels of retinol and beta-carotene with breast cancer: results of a case-control study. Cancer 1988;61:173-80.
120. Russell MJ, Thomas BS, Bulbrook RD. A prospective study of the relationship between serum vitamins A and E and risk of breast cancer. Br J Cancer 1988;57:213-15.
121. Wald NJ, Borcham J, Haywood JL, et al. Plasma retinol, β-carotene and vitamin E levels in relation to the future of risk of breast cancer. Br J Cancer 1984;49:321-4.
122. Peleg I, Heyden S, Knowles M, et al. Serum retinol and risk of subsequent cancer: extension of the Evans County, Georgia study. J Natl Cancer Inst 1984;73:1455-8.
123. Thompson JH, Becci PJ. Selenium inhibition of IV-methyl-N-nitrosourea-induced mammary carcinogenesis in the rat. J Natl Cancer Inst 1980;65:1299-1301.
124. Noord PAH, Collette HJA, Maas MJ, et al. Selenium levels in nails of premenopausal breast cancer patients assessed prediagnostically in a cohort-nested case-referent study among women screened in the DOM Project. Int J Epidemiol 1987;16 (suppl):318-22.
125. Meyer F, Verreault R. Erythrocyte selenium and breast cancer risk. Am J Epidemiol 1987;125: 917-19.
126. Rohan TE, Bain CJ. Diet in the etiology of breast cancer. Epidemiol Rev 1987;9:120-45.
127. Iscovich JM, Iscovich RB, Howe G, et al. A case- control study of diet and breast cancer in Argentina. Int J Cancer 1989;44:770-6.
128. Willett W. The search for the causes of breast and colon cancer. Nature 1989;338:389-94.
129. Hiatt RA, Bawol RD. Alcoholic beverage consumption and breast cancer incidence. Am J Epidemiol 1984;120:676-83.
130. La Vecchia C, Decarli A, Franceschi S, et al. Alcohol consumption and the risk of breast cancer in women. J Natl Cancer Inst 1985;75:61-5.
131. Harvey EB, Schairer C, Brinton LA, et al. Alcohol consumption and breast cancer. J Natl Cancer Inst 1987;78:657-61.
132. O’Connell DL, Hulka BS, Chambless LE, et al. Cigarette smoking, alcohol consumption, and breast cancer risk. J Natl Cancer Inst 1987; 78:229-34.
133. Schatzkin A, Jones DY, Hoover RN, et al. Alcohol consumption and breast cancer in the epidemiologic follow-up study of the first National Health and Nutrition Examination Survey. N Engl J Med 1987;316:1169-73.
134. Willett WC, Stampfer MJ, Colditz GA, et al. Moderate alcohol consumption and the risk of breast cancer. N Engl J Med 1987;316:1174-80.
135. Garfinkel L, Boffetta P, Stellman SD. Alcohol and breast cancer: a cohort study. Prev Med 1988;17:686-93.
136. Hiatt RA, Klatsky AL, Armstrong MA. Alcohol consumption and the risk of breast cancer in a prepaid health plan. Cancer Res 1988;48:2284-7.
137. Rohan TE, McMichael AJ. Alcohol consumption and risk of breast cancer. Int J Cancer 1988; 41:695-9.
138. Richardson S, Vincenzi I, Pujol H, et al. Alcohol consumption in a case-control study of breast cancer in southern France. Int J Cancer 1989;44:84-9.
139. Toniolo P, Riboli E, Protta F, et al. Breast cancer and alcohol consumption: a case-control study in northern Italy. Cancer Res 1989;49:5203-6.
140. Young TB. A case-control study of breast cancer and alcohol consumption habits. Cancer 1989; 64:552-8.
141. Lê MG, Moulton LH, Hill C, et al. Consumption of dairy produce and alcohol in a case-control study of breast cancer. J Natl Cancer Inst 1986;77:633-6.
142. Adami HO, Lund E, Bergstrom R, et al. Cigarette smoking, alcohol consumption and risk of breast cancer in young women. Br J Cancer 1988;58:832-7.
143. Harris RE, Wynder EL. Breast cancer and alcohol consumption: a study in weak associations. JAMA 1988;259:2867-71.
144. Chu SY, Lee NC, Wingo PA, et al. Alcohol consumption and the risk of breast cancer. Am J Epidemiol 1989;130:867-77.
145. Meara J, McPherson K, Roberts M, et al. Alcohol, cigarette smoking and breast cancer. Br J Cancer 1989;60:70-3.
146. Schatzkin A, Carter CL, Green SB, et al. Is alcohol consumption related to breast cancer? Results from The Framingham Heart Study. J Natl Cancer Inst 1989;81:31-5.
147. Rosenberg L, Palmer JR, Miller DR, et al. A case-control study of alcoholic beverage consumption and breast cancer. Am J Epidemiol 1990;131:6-14.
148. van’t Veer P, Kok FJ, Hermus RJJ, et al. Alcohol dose, frequency and age at first exposure in relation to the risk of breast cancer. Int J Epidemiol 1989;18:511-17.
149. Freund G. Possible relationships of alcohol in membranes to cancer. Cancer Res 1979;39: 2899-2901.
150. Wickramasinghe SN, Gardner B, Borden G. Cytotoxic protein molecules generated as a consequence of ethanol metabolism in vitro and in vivo. Lancet 1986;2:823-6.
151. Lieber CS, Seitz HK, Garro AJ, et al. Alcohol- related disease and carcinogenesis. Cancer Res 1979;39:1497-1504.
152. Swann PF, Coe AM, Mace R. Ethanol and di- methylnitrosamine and diethylnitrosamine metabolism and deposition in the rat: possible relevance to the influence of ethanol on human cancer incidence. Carcinogenesis 1984;5:1337-43.
153. Lawson DH, Jick H, Rothman KJ. Coffee and tea consumption and breast disease. Surgery 1981;90:801-3.
154. Mansel RE, Webster DJT, Burr M, et al. Is there a relationship between coffee consumption and breast disease? Br J Surg 1982;69:295-6.
155. Baron JA. Smoking and estrogen-related disease. Am J Epidemiol 1984;119:9-22.
156. Schechter MT, Miller AB, Howe GR, et al. Cigarette smoking and breast cancer: case-control studies of prevalent and incident cancer in the Canadian National Breast Screening Study. Am J Epidemiol 1989;130:213-20.
157. Lubin F, Ron E, Wax Y, et al. Coffee and meth- ylxanthines and breast cancer: a case-control study. J Natl Cancer Inst 1985;74:569-73.
158. Rosenberg L, Miller DR, Helmrich SP, et al. Breast cancer and the consumption of coffee. Am J Epidemiol 1985;122:391-9.
159. Jacobsen BK, Bjelke E, Kvâle G, et al. Coffee drinking, mortality and cancer incidence: results from a Norwegian prospective study. J Natl Cancer Inst 1986;76:823-31.
160. Schairer C, Brinton LA, Hoover RN. Methylxan- thines and breast cancer. Int J Cancer 1987; 40:469-73.
161. Rohan TE, McMichael AJ. Methylxanthines and breast cancer. Int J Cancer 1988;41:390-3.
162. Smith EM, Sowers MF, Burns TL. Effects of smoking on the development of female reproductive cancers. J Natl Cancer Inst 1984;73:371-6.
163. Rosenberg L, Schwingl PJ, Kaufman DW, et al. Breast cancer and cigarette smoking. N Engl J Med 1984;310:92-4.
164. Baron JA, Byers T, Greenberg ER, et al. Cigarette smoking in women with cancers of the breast and reproductive organs. J Natl Cancer Inst 1987;77:677-80.
165. Brinton LA, Schairer C, Stanford JL, et al. Cigarette smoking and breast cancer. Am J Epidemiol 1986;123:614-22.
166. Hiatt RA, Fireman BH. Smoking, menopause, and breast cancer. J Natl Cancer Inst 1986; 76:833-8.
167. London SJ, Colditz GA, Stampfer MJ, et al. Prospective study of smoking and the risk of breast cancer. J Natl Cancer Inst 1989;81:1625-31.
168. Rohan TE, Baron JA. Cigarette smoking and breast cancer. Am J Epidemiol 1989;129:36-42.
169. Frisch RE, Wyshak G, Albright NL, et al. Lower prevalence of breast cancer and cancers of the reproductive system among former college athletes compared to nonathletes. Br J Cancer 1985;52:885-91.
170. Albanes D, Blair A, Taylor PR. Physical activity and risk of cancer in the NHANES I population. Am J Public Health 1989;79:744-50.
171. Bernstein L, Ross RK, Lobo RA, et al. The effects of moderate physical activity on menstrual cycle patterns in adolescence: implications for prevention. Br J Cancer 1987;55:681-5.
172. Ellison PT, Lager C. Moderate recreational running is associated with lowered salivary progesterone profiles in women. Am J Obstet Gynecol 1986;154:1000-3.
173. Fisher EC, Nelson ME, Frontera WR, et al. Bone mineral content and levels of gonadotropins and estrogens in amenorrheic running women. J Clin Endocrinol Metab 1986;62:1232-6.
174. Stevens RG. Electric power use and breast cancer: a hypothesis. Am J Epidemiol 1987;125:556-61.
175. Wertheimer N, Leeper E. Magnetic field exposure related to cancer subtypes. Ann N Y Acad Sci 1987;502:43-53.
176. McDowall ME. Mortality of persons resident in the vicinity of electricity transmission facilities. Br J Cancer 1986;53:271-9.
177. Dupont WD, Page DL. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 1985;312:146-51.
178. Dupont WD, Page DL. Breast cancer risk associated with proliferative disease, age at first birth, and a family history of breast cancer. Am J Epidemiol 1987;125:769-79.
179. Hutchinson WB, Thomas DB, Hamlin WB, et al. Risk of breast cancer in women with benign breast disease. J Natl Cancer Inst 1980;65:13-20.
180. Consensus Meeting. Is fibrocystic disease of the breast precancerous? Arch Pathol Lab Med 1986;110:171-3.
181. Jensen RA, Page DL, Dupont WD, et al. Invasive breast cancer risk in women with sclerosing adenosis. Cancer 1989;64:1977-83.
182. Schwartz AG, King MC, Belle SJH, et al. Risk of breast cancer to relatives of young breast cancer patients. J Natl Cancer Inst 1985;75:665-8.
183. Sattin RW, Rubin GL, Webster LA, et al. Family history and the risk of breast cancer. JAMA 1985;253:1908-13.
184. Anderson DE, Badzioch MD. Risk of familial breast cancer. Cancer 1985;56:383-7.
185. Ottman R, Pike MC, King MC, et al. Practical guide for estimating risk for familial breast cancer. Lancet 1983;2:556-8.
186. Ottman R, Pike M-C, King MC, et al. Familial breast cancer in a population-based series. Am J Epidemiol 1986;123:15-21.
187. Swift M, Reitnauer PJ, Morrell D, et al. Breast and other cancers in families with ataxia- telangiectasia. N Engl J Med 1987;316:1289-94.
188. Newman B, Austin MA, Lee M, et al. Inheritance of human breast cancer: evidence for autosomal dominant transmission in high-risk families. Proc Natl Acad Sci USA 1988;85:3044-8.
189. Hrubec Z, Boice JD Jr, Monson RR, et al. Breast cancer after multiple chest fluoroscopies: second follow-up of Massachusetts women with tuberculosis. Cancer Res 1989;49:229-234.
190. Miller AB, Howe GR, Sherman GJ, et al. Mortality from breast cancer after irradiation during fluoroscopic examination in patients being treated for tuberculosis. N Engl J Med 1989; 321:1285-9.
191. Tokunaga M, Land CE, Yamamoti T, et al. Breast cancer in Japanese A-bomb survivors. Lancet 1982;2:924.
192. Modan B, Alfandary E, Chetrit A, et al. Increased risk of breast cancer after low-dose irradiation. Lancet 1989;1:629-31.
193. Hoffman DA, Lonstein JE, Morin MM, et al. Breast cancer in women with scoliosis exposed to multiple diagnostic x-rays. J Natl Cancer Inst 1989;81:1307-12.
194. Hildreth NG, Shore RE, Hempelmann LH. Risk of extra-thyroid tumors following radiation treatment in infancy for thymic enlargement. Radiat Res 1985;102:378-91.
195. Hildreth NG, Shore RE, Dvoretsky PM. The risk of breast cancer after irradiation of the thymus in infancy. N Engl J Med 1989;321:1281-4.
196. Shore RE, Hildreth N, Woodward E, et al. Breast cancer among women given x-ray therapy for acute post-partum mastitis. J Natl Cancer Inst 1986;77:689-96.
197. Storm HH, Iversen E, Boice JD. Breast cancer following multiple chest fluoroscopies among tuberculosis patients: a case-control study in Denmark. Acta Radiol [Oncol] 1986;25:233-8.
198. Boice JD Jr, Land CE, Shore RE, et al. Risk of breast cancer following low-dose radiation exposure. Radiology 1979;131:589-97.
199. Verbeek ALM, Hendriks JHCL, Holland R, et al. Mammographie screening and breast cancer mortality: age-specific effects in Nijmegen project, 1975-1982. Lancet 1985;1:865-6.
200. Collette HJ, Day NE, Rombach JJ, et al. Evaluation of screening for breast cancer in a non- randomized study (the DOM project) by means of a case-control study. Lancet 1984;1:1224-6.
201. Tabar L, Gad A, Holmberg LH, et al. Reduction in mortality from breast cancer after mass screening with mammography. Lancet 1985; 1: 829-32.
202. Palli D, Rosselli Del Turco M, Buiatti E, et al. A case-control study of the efficacy of a non- randomized breast cancer screening program in Florence (Italy). Int J Cancer 1986;38:501-4.
203. Habbema JDF, Oortmarssen GJ, Patten DJ, et al. Age-specific reduction in breast cancer mortality by screening: an analysis of the results of the Health Insurance Plan of Greater New York study. J Natl Cancer Inst 1986;77:317-20.
204. Eddy DM, Hasselblad V, McGivney W, et al. The value of mammography screening in women under age 50 years. JAMA 1988;259:1512-19.
205. Fischer ER, Fisher B, Sass R, et al. Pathologic findings from the National Surgical Adjuvant Breast Project (protocol no 4). XI. Bilateral breast cancer. Cancer 1984;54:3002-11.
206. Anderson DE, Badzioch MD. Bilaterality in familial breast cancer patients. Cancer 1985;56: 2092-8.
207. Horn PL, Thompson WD. Risk of contralateral breast cancer: associations with factors related to initial breast cancer. Am J Epidemiol 1988;128:309-23.
208. Hankey BF, Curtis RE, Naughton MD, et al. A retrospective cohort analysis of second breast cancer risk for primary breast cancer patients with an assessment of the effect of radiation therapy. J Natl Cancer Inst 1983;70:797-804.
209. Bums PE, Dabbs K, May C, et al. Bilateral breast cancer in northern Alberta: risk factors and survival patterns. Can Med Assoc J 1984; 130:881-6.
210. Hislop TG, Elwood JM, Coldman AJ, et al. Second primary cancers of the breast: incidence and risk factors. Br J Cancer 1984;49:79-85.
211. Nielsen M, Christensen L, Andersen J. Contralateral cancerous breast lesions in women with clinical invasive breast carcinoma. Cancer 1986; 57:897-903.
212. Horn PL, Thompson WD, Schwartz SM. Factors associated with the risk of second primary breast cancer: an analysis of data from the Connecticut Tumor Registry. J Chronic Dis 1987;40:1003-11.
213. Horn PL, Thompson WD. Risk of contralateral breast cancer: associations with histologic, clinical, and therapeutic factors. Cancer 1988;62: 412-24.
214. Trichopoulos D, Brown J, MacMahon B. Urine estrogens and breast cancer risk factors among post-menopausal women. Int J Cancer 1987; 40:721-5.
215. de Waard F, Trichopoulos D. A unifying concept of the aetiology of breast cancer. Int J Cancer 1988;41:666-9.
216. Key TJA, Pike MC. The role of oestrogens and progestogens in the epidemiology and prevention of breast cancer. Eur J Cancer Clin Oncol 1988;24:29-43.
217. L’Hermite M, L’Hermite-Baleriaux M. Prolactin and breast cancer. Eur J Cancer Clin Oncol 1988;24:955-8.
218. Thomas DB. Do hormones cause breast cancer? Cancer 1984;53:595-604.
219. Moore JW, Clark GMG, Hoare SA, et al. Binding of oestradiol to blood proteins and aetiology of breast cancer. Int J Cancer 1986;38:625-30.
220. Takatani O, Kosano H, Okumoto T, et al. Distribution of estradiol and percentage of free testosterone in sera of Japanese women: preoperative breast cancer patients and normal controls. J Natl Cancer Inst 1987;79:1199-1204.
221. Takatani O, Okumoto T, Kosano H, et al. Relationship between the levels of serum thyroid hormones or estrogen status and the risk of breast cancer genesis in Japanese women. Cancer Res 1989;49:3109-12.
222. Wysowski DK, Comstock GW, Helsing KJ, et al. Sex hormone levels in serum in relation to the development of breast cancer. Am J Epidemiol 1987;125:791-9.
223. Enriori CL, Reforzo-Membrives J. Peripheral aromatization as risk factor for breast and endometrial cancer in postmenopausal women. Gynecol Oncol 1984;17:1-21.
224. Secreto G, Toniolo P, Pisani P, et al. Androgens and breast cancer in premenopausal women. Cancer Res 1989;49:471-6.
225. Meyer F, Brown JB, Morrison AS, et al. Endogenous sex hormones, prolactin, and breast cancer in premenopausal women. J Natl Cancer Inst 1986;77:613-16.
226. Thomas BS, Bulbrook RD, Goodman MJ, et al. Thyroid function and the incidence of breast cancer in Hawaiian, British and Japanese women. Int J Cancer 1986;38:325-9.
227. Emster VL, Wrensch MR, Petrakis NL, et al. Benign and malignant breast disease: initial study results of serum and breast fluid analyses of endogenous estrogens. J Natl Cancer Inst 1987;79:949-60.
228. Petrakis NL, Wrensch MR, Ernster VL, et al. Influence of pregnancy and lactation on serum and breast fluid estrogen levels: implications for breast cancer risk. Int J Cancer 1987;40:587-91.
229. Gruenke LD, Wrensch MR, Petrakis NL, et al. Breast fluid cholesterol and cholesterol epoxides: relationship to breast cancer risk factors and other characteristics. Cancer Res 1987;47:5483-7.
230. Wrensch MR, Petrakis NL, Gruenke LD, et al. Breast fluid cholesterol and cholesterol epoxide concentrations in women with benign breast disease. Cancer Res 1989;49:2168-74.